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Infection of neuronal cells by Chlamydia pneumoniae and Herpes simplex 
virus type 1 alters expression of genes associated with Alzheimer’s disease
Several studies have suggested an infectious etiology for Alzheimer’s disease (AD). We
have been investigating a potential role for both Chlamydia pneumoniae and Herpes sim-
plex virus type 1 (HSV1) in the initiation of sporadic late-onset AD.  Our current study
focuses on investigation of gene expression using Alzheimer-specific Real-Time PCR
microarrays on RNA derived from SKNMC human neuronal cells infected with 
C. pneumoniae and/or HSV1.  There are distinct differences in the patterns of gene reg-
ulation by the two pathogens.  For example, C. pneumoniae induces expression of genes
involved in amyloid production and processing, such as β-amyloid precursor protein
(APP), β-site APP-cleaving enzyme 1 (BACE1), a γ-secretase complex protein (nicastrin
[NCSTN]), NEDD8 activating enzyme E1 (NAE1), as well as a mitochondria-associat-
ed protein (hydroxysteroid (17-β) dehydrogenase 10 [HSD17B10]), α-2-macroglobulin
(A2M) and the metallopeptidase ADAM9.  Conversely, HSV1 tends to down-regulate
expression of many genes, including those encoding a component of the γ-secretase com-
plex (anterior pharynx defective 1 homolog A [APH1A]), low density lipoprotein related
proteins (LRP1, LRP6, and LRP8), β-synuclein (SNCB) and ubiquinols (UQCRC1,
UQCRC2).  Co-infection with C. pneumoniae and HSV-1 produced a greater down-reg-
ulation of gene expression than that seen with HSV1 alone for several genes, including
APP-like proteins (APLP1, APLP2) and kinases (cell division cycle 2 protein [CDC2],
cyclin-dependent kinase [CDK5] and CDC2-related kinase [CDKL1]).  Our data indi-
cate that both C. pneumoniae and HSV1 can modulate expression of genes associated
with AD, and thus could contribute to AD pathology, however these two pathogens like-
ly act via different pathways.  Furthermore, for several genes, co-infection with both 
C. pneumoniae and HSV1 appears to exacerbate the changes in gene expression seen with
HSV1 alone.
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Alzheimer’s disease (AD) is the leading cause of dementia, and while a genetic predisposi-
tion can account for a small percentage of the cases, the majority of cases are the result of a
multifactorial etiology that may include infectious agents (Honjo et al., 2009).  Infection
within the central nervous system (CNS) by Herpes simplex virus type 1 (HSV1) and
Chlamydia pneumoniae has been suggested to play a role in sporadic AD (Itzhaki et al.,
2004).  In this study we examine the possibility that C. pneumoniae and/or HSV1 will alter
the expression of genes associated with AD.  This would provide additional evidence that
these pathogens might contribute to onset or progression of the pathology associated with
AD, and thus play a role in the disease process.
Previous studies have indicated that C. pneumoniae is detected in the brains of patients with
AD more frequently than in normal aged brains (Balin et al., 1998; Gerard et al., 2006).
In the AD brains, C. pneumoniae antigens were present in macrophages, microglia, and
astroglial cells of the temporal cortex, hippocampus, parietal, and pre-frontal cortices
(Itzhaki et al., 2004).  We postulate that C. pneumoniaemight enter the central nervous sys-
tem (CNS) through either an intravascular or olfactory route.  In support of this hypothe-
sis, C. pneumoniae-infected glial, macrophages, and monocytes were all identified around
blood vessels and in olfactory bulbs (Balin et al., 2004).
Studies have also implicated HSV1 as a potential pathogen contributing to AD pathology
(Itzhaki et al., 2004).  HSV1 is ubiquitous and produces latent infection in neurons, with
the potential for reactivation in the CNS.  The chronic nature of this infection, with peri-
odic reactivation of productive infection, may contribute to the gradual accumulation of
pathology associated with AD.  It has been shown that HSV1 can produce abnormal pro-
cessing of amyloid precursor protein, which results in the deposition of amyloid plaques, an
important pathological feature of AD (Dobson et al., 2002; Wozniak et al., 2007).
Furthermore, herpesvirus DNA has been detected in plaques in AD brains (Wozniak et al.
2009), additional evidence that HSV1 may contribute to AD disease progression.
The role that C. pneumoniae and/or HSV1 plays in “triggering” events resulting in AD
pathology has been further analyzed following in vitro infection of the human neuronal cell
line, SKNMC.  Experiments were designed to determine whether infection with 
C. pneumoniae and HSV1, either singly or in combination, influences the expression of 
cellular genes associated with AD.  We have analyzed AD-associated gene expression in neu-
ronal cells in the presence or absence of the two pathogens using microarray technology.
These data may provide further insight into how these two pathogens might contribute to
the onset or progression of Alzheimer’s disease.  The inclusion of co-infections by both 
C. pneumoniae and HSV1 in this study will also examine possible synergistic affects of
multiple pathogens on the disease process.
 It is possible for a single cell to be infected with both C. pneumoniae and HSV1
 When both pathogens are added simultaneously, HSV1 infection of SKNMC cells
appear to dominate over that of C. pneumoniae
 The % of SKNMC cells showing low levels of infection with C. pneumoniae
(< 3 Cpn bodies) remained relatively constant over 24 and 48 hours, regardless of
whether HSV1 was present or not
 The % of SKNMC cells showing more extensive infection with C. pneumoniae
(> 3 Cpn bodies) increased over time in the absence of HSV1, but was consistently
lower in 48 hour co-infections compared to 48 hour infections with C. pneumoniae
alone
 The affect of C. pneumoniae or HSV1 infection on SKNMC cells was more 
variable, with 3 of 5 infections showing a decrease in % HSV1 positive cells, while
2 of 5 infections showing an increase.
Although the changes were not dramatic, infection of SKNMC cells with 
C. pneumoniae resulted in the up-regulation of numerous genes, especially genes
involved in theprocessing of β-amyloid and select cell signaling genes
 Infection of SKNMC cells with HSV1 resulted in the down-regulation of most genes
in the array, though genes involved in β-amyloid processing were generally not affect-
ed to the same extent as genes involved in lipoprotein metabolism.
The expression of genes in co-infected monolayers was down-regulated as seen 
following infection with HSV1 alone, with numerous genes, such as several of the
protein kinases and select cell signaling genes, showing greater down-regulation in 
co-infections than in HSV1 infection alone
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Figure 1 Immunofluorescence labeling of SKNMC cells infected by C. pneumoniae (green) for 48
hours (left panel), HSV1 (red) for 24 hours (middle panel) or co-infected (right panel) with both C.
pneumoniae (48 hours) and HSV1 (24 hours).  Nuclei are shown in blue. 
Figure 4 Changes in gene expression following infection of SKNMC cells with C. pneumoniae or
HSV1 alone, or co-infected with both pathogens.  Cells were infected with C. pneumoniae for 48
hours and HSV1 for 24 hours.  For co-infections, cells were inoculated with C. pneumoniae first,
inoculated with HSV1 after 24 hours, then harvested after an additional 24 hours (co-infection
[48/24]).  RNA was isolated and analyzed by RT2-PCR using a microarray for Alzheimer-associated
genes (SABiosciences). The results shown are pooled from 6 separate infections.  Only select genes
with the greatest changes, either up- or down-regulation, are shown.
Figure 2 Representative infection of SKNMC cells by C. pneumoniae (Cpn) and HSV1. Cells were
infected with C. pneumoniae for 24 or 48 hours or with HSV1 for 24 hours at an MOI of 0.5.  For
co-infections, cells were inoculated with C. pneumoniae and HSV together and incubated for 24
hours (co-infection [24/24]) before harvesting, or inoculated first with C. pneumoniae alone for 24
hours, then with HSV1 for an additional 24 hours (co-infection [48/24]) before harvesting.  Cells
were labeled for C. pneumoniae and/or HSV1 by immunofluorescence and the % of cells labeled for
each pathogen was quantified.  Cells showing low levels of C. pneumoniae labeling (< 3 Cpn bod-
ies) were scored separately from cells demonstrating more extensive C. pneumoniae infection (> 3
Cpn bodies).  Four fields, each typically containing between 75 and 100 cells/field, were counted for
each infected monolayer.
Figure 3 Comparison of % C. pneumoniae (Cpn)- or HSV1-infected cells in monolayers inoculated
with a single pathogen or co-infected with both pathogens from 5 separate infections.  Cells were
infected with C. pneumoniae for 48 hours and HSV1 for 24 hours at an MOI of 0.5.  For co-infec-
tions, cells were inoculated with C. pneumoniae first, inoculated with HSV1 after 24 hours, then
harvested after an additional 24 hours (co-infection [48/24]).  Cells were labeled for C. pneumoniae
and/or HSV1 by immunofluorescence and the % of cells labeled for each pathogen was quantified.
Cells showing low levels of C. pneumoniae labeling (< 3 Cpn bodies) were scored separately from
cells demonstrating more extensive C. pneumoniae infection (> 3 Cpn bodies). Four fields, each 
typically containing between 75 and 100 cells/field, were counted for each infected monolayer.
Function Gene symbol Gene name
b-amyloid processing & clearance
Secretases ADAM9 ADAM metallopeptidase domain 9
APH1A Anterior pharynx defective 1 homolog A (C. elegans)
BACE1 b-site APP-cleaving enzyme 1
CTSB Cathepsin B
NCSTN Nicastrin
Other peptidases IDE Insulin-degrading enzyme
PLG Plasminogen
b-amyloid clearance through APLP1 b-amyloid precursor-like protein 1
endocytosis APP b-amyloid precursor protein
LRP6 LDL receptor-related protein 6
Other genes involved in A2M a-2-macroglobulin
b-amyloid metabolism APBB2 b-amyloid precursor protein-binding, family B, member 2
UBQLN1 Ubiquilin 1
Lipid/lipoprotein metabolism
LRP1 LDL-related protein 1 (a -2-macroglobulin receptor)






CDC2 Cell division cycle 2, G1 to S & G2 to M
CDK5 Cyclin-dependent kinase 5
CDKL1 Cyclin-dependent kinase-like 1 (CDC2-related kinase)
PRKCE Protein kinase C, 
Cell signaling molecules
G-protein coupled receptor APLP2 b-amyloid precursor-like protein 2
GNAO1 G protein, a  activating activity polypeptide O
GNAZ G protein, a z polypeptide
GNB5 G protein, b  5
GNG10 G protein, g  10
GNG5 G protein, g  5
GNG8 G protein, g  8
GNGT2 G protein, g transducing activity polypeptide 2
Other signaling molecules GAP43 Growth associated protein 43
IL1A Interleukin 1,a
INSR Insulin receptor
NAE1 NEDD8 activating enzyme E1 subunit 1
Oxidoreductases & oxidative stress
HSD17B10 Hydroxysteroid (17-b ) dehydrogenase 10
UQCRC1 Ubiquinol-cytochrome c reductase core protein I
UQCRC2 Ubiquinol-cytochrome c reductase core protein II
 HSV1 appears to inhibit C. pneumoniae growth in SKNMC cells
 The decrease in % of cells with multiple C. pneumoniae bodies may
reflect an inhibition of chlamydial attachment to SKNMC cells 
 The down-regulation of most of the genes in the Alzheimer disease microar-
ray by infection with HSV1 may reflect a general ability of viruses to shut
down host gene synthesis
 Gene regulation in co-infected monolayers is similar to that seen with
HSV1 alone, as opposed to being intermediate between the up-regulation
seen with C. pneumoniae and the down-regulation seen with HSV1
 HSV1 infection dominates over that of C. pneumoniae in co-infected
monolayers, consistent with quantification of infection in single vs co-
infections
 C. pneumoniae could directly contribute to amyloid plaque formation, an
important pathological feature of Alzheimer’s disease, by enhancing expres-
sion of genes involved in the processing of β-amyloid
 The most likely scenario to account for a C. pneumoniae/HSV1 co-infection
would be dissemination of C. pneumoniae to the CNS of an individual with
latent HSV1 infection.  Our data suggest:
 HSV1 would be able to reactivate in the presence of active 
C. pneumoniae infection
 Productive HSV1 infection, however, might limit the C. pneumoniae
infection
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